Screening and Early Detection
Pancreatic cancer is too often diagnosed in late stages. Early detection of pancreatic cancer can make a big difference in a patient's outcome. How are researchers identifying those at highest risk and what screening tests are tests are under development?
30 Articles
Studying a New Approach for the Liquid Biopsy
Drs. Allyson Ocean and Ying-Hsiu Su lead a liquid biopsy pilot study looking for KRAS proteins in urine, to detect pancreatic cancer.
Artificial Intelligence and Early Detection of Pancreatic Cancer
How can AI be used in the early detection of pancreatic cancer? Dr. Michael Rosenthal reviews the current state of the field.
PATHFINDER Blood Test Trial Focused on Early Detection
Dr. Minetta Liu is part of the team conducting a clinical trial to find biomarkers that will become an easy blood test for pancreatic cancer.
Earlier Detection of Pancreatic Cancer: A Marathon, Not A Sprint
Dino Verrelli of Project Purple joins with Dr. Diane Simeone on the PRECEDE Consortium to develop earlier detection and new pancreatic cancer treatments.
Searching for Potential Pancreatic Cancer Blood Biomarkers
Researchers are using blood samples to follow people considered at risk for developing pancreatic cancer in a trial looking for early detection biomarkers.
Machine-Learning Assay May Improve Pancreatic Cyst Management
Dr. Anne Marie Lennon explains CompCyst, the artificial intelligence-based assay that can determine the best treatment for pancreatic cysts.
Which Is the Best Screening Method for Pancreatic Cancer?
Dr. Aimee Lucas outlines the pros and cons of various screening methods that can be used for pancreatic cancer, and who should be using them.
Man + Machine: Using Deep Learning for Early Detection of Pancreatic Cancer
Dr. Elliot Fishman is part of a team that is using artificial intelligence, or deep learning to develop techniques for early detection of pancreatic cancer.
Early Detection Trial for People at Higher Risk of Pancreatic Cancer
Relatives of pancreatic cancer patients or people who carry certain mutations can participate in an early detection clinical trial.
A Simple Blood Test for Early Detection of Eight Cancers Shows Promise
Dr. Anne Marie Lennon explains the CancerSEEK blood test, a liquid biopsy in clinical trials for early detection of eight cancers, including pancreatic.
A Newly Identified Biomarker Panel Shows Promise in Earlier Pancreatic Cancer Detection
The first pancreatic cancer blood test may soon be a reality, as a biomarker panel from the lab of Dr. Ken Zaret shows promise in early testing.
Developing a Screening Test for Pancreatic Cancer
One focus of research for Dr. Anirban Maitra is to develop a simple screening test for pancreatic cancer, to provide an earlier diagnosis of the disease.
New Biopsy Shows Promise For Pancreatic Cancer Patients
Trovagene is developing a liquid biopsy for pancreatic cancer patients, to allow doctors to test for cancer and track treatment response.
Can a Pancreatic Cancer Screening Test Become a Reality?
Dr. Felice Schnoll-Sussman discusses screening options for pancreatic cancer and criteria for people who might want to get screened.
A Liquid Biopsy for Pancreatic Cancer
Dr. Bert Vogelstein and his team at Johns Hopkins are working with a blood test called a liquid biopsy, which tests cells for mutations related to cancer.